Nuvation Bio Inc. (NUVB)
NYSE: NUVB · IEX Real-Time Price · USD
3.740
+0.050 (1.36%)
At close: Jul 26, 2024, 4:00 PM
3.830
+0.090 (2.41%)
After-hours: Jul 26, 2024, 7:28 PM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $926.28 million as of July 26, 2024. Its market cap has increased by 146.16% in one year.
Market Cap
926.28M
Enterprise Value
320.45M
1-Year Change
146.16%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since July 1, 2020, Nuvation Bio's market cap has increased from $181.60M to $926.28M, an increase of 410.07%. That is a compound annual growth rate of 49.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 912.10M | 175.89% |
| Dec 29, 2023 | 330.60M | -21.15% |
| Dec 30, 2022 | 419.30M | -77.35% |
| Dec 31, 2021 | 1.85B | 757.43% |
| Dec 31, 2020 | 215.90M | 18.89% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Embecta | 928.20M |
| AbCellera Biologics | 917.45M |
| HealthStream | 916.19M |
| 89bio | 904.15M |
| Immunome | 894.20M |
| Cogent Biosciences | 889.20M |
| The Pennant Group | 886.20M |
| GeneDx Holdings | 882.07M |